Nature Communications (Apr 2024)

BIN1 knockdown rescues systolic dysfunction in aging male mouse hearts

  • Maartje Westhoff,
  • Silvia G. del Villar,
  • Taylor L. Voelker,
  • Phung N. Thai,
  • Heather C. Spooner,
  • Alexandre D. Costa,
  • Padmini Sirish,
  • Nipavan Chiamvimonvat,
  • Eamonn J. Dickson,
  • Rose E. Dixon

DOI
https://doi.org/10.1038/s41467-024-47847-8
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Cardiac dysfunction is a hallmark of aging in humans and mice. Here we report that a two-week treatment to restore youthful Bridging Integrator 1 (BIN1) levels in the hearts of 24-month-old mice rejuvenates cardiac function and substantially reverses the aging phenotype. Our data indicate that age-associated overexpression of BIN1 occurs alongside dysregulated endosomal recycling and disrupted trafficking of cardiac CaV1.2 and type 2 ryanodine receptors. These deficiencies affect channel function at rest and their upregulation during acute stress. In vivo echocardiography reveals reduced systolic function in old mice. BIN1 knockdown using an adeno-associated virus serotype 9 packaged shRNA-mBIN1 restores the nanoscale distribution and clustering plasticity of ryanodine receptors and recovers Ca2+ transient amplitudes and cardiac systolic function toward youthful levels. Enhanced systolic function correlates with increased phosphorylation of the myofilament protein cardiac myosin binding protein-C. These results reveal BIN1 knockdown as a novel therapeutic strategy to rejuvenate the aging myocardium.